Individuals with MAFLD-lean often possess specific genetic profiles, such as PNPLA3 or TM6SF2 risk alleles, and unique gut microbiomes that contribute to fatty liver development (Chen et al., 2020). Here, PNPLA3 is linked to Hepatic steatosis.